AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsTechnology, Industry, AgricultureInformation ScienceHealth CareGeographicals
Myocardial InfarctionInfarctionElectrocardiographyCerebral InfarctionAngioplasty, Balloon, CoronaryThrombolytic TherapyCoronary AngiographyTime FactorsAnterior Wall Myocardial InfarctionMyocardial ReperfusionRisk FactorsVentricular RemodelingTreatment OutcomeProspective StudiesStreptokinaseCreatine KinaseMyocardiumCoronary Care UnitsVentricular Function, LeftFibrinolytic AgentsCoronary DiseasePrognosisAngina PectorisPlatelet Aggregation InhibitorsFollow-Up StudiesAngina, UnstablePredictive Value of TestsStentsPercutaneous Coronary InterventionMyocardial RevascularizationCoronary ThrombosisRecurrenceMyocardial IschemiaEchocardiographyCoronary VesselsShock, CardiogenicCoronary Artery DiseaseInferior Wall Myocardial InfarctionRisk AssessmentVentricular Dysfunction, LeftHospital MortalityCoronary CirculationStroke VolumeAcute DiseaseRetrospective StudiesChest PainBiological MarkersHeart FailureHeartCoronary Artery BypassProportional Hazards ModelsRegistriesIncidenceStrokeAspirinHeart VentriclesAcute Coronary SyndromeCohort StudiesTissue Plasminogen ActivatorSurvival AnalysisArrhythmias, CardiacHeart Rupture, Post-InfarctionMultivariate AnalysisHospitalizationClinical Enzyme TestsCase-Control StudiesDrug-Eluting StentsCardiac CatheterizationHemorrhageTroponin TRiskDeath, Sudden, CardiacTroponin ICardiovascular AgentsAdrenergic beta-AntagonistsMyocardial Reperfusion InjuryHemodynamicsLogistic ModelsSurvival RateTiclopidineThrombosisDisease Models, AnimalCardiovascular DiseasesAge FactorsCardiotonic AgentsKaplan-Meier EstimateRandomized Controlled Trials as TopicChi-Square DistributionCoronary OcclusionCoronary StenosisOdds RatioEmergency Medical ServicesTomography, Emission-Computed, Single-PhotonSplenic InfarctionDouble-Blind MethodSex FactorsHeparinAnticoagulantsDiabetes ComplicationsMyocardial Contraction
ElevationPrimary percutaneous coronary intSTEMIIschemiaMethodsCardiogenic shockThrombolytic therapyUnstable anginaAdmitted with acuteMorbidityNecrosisDelayed in patients with acutePercutaneousCardiovascularComplicationsIncidence and outcomeClinicalLate gadolinium enhancementHeart FailureCardiacOutcomeAbstractMiddle AgedInfarct sizePrognosisComplicationChest painConclusionVersusMortality among patientsDiabetesOutcomes of patientsHbA1cOdds RatioYoung patientsCohortDiagnosisObjectiveRiskProspectivelyEvaluateSignificantly increasedCoronary lesionsCHRONIC KIDNEY-AdverseDiabetic patientsCharacteristicsConsecutivePrognostic value
Elevation12
  • The benefits of supplemental administration of intravenous magnesium in patients with ST-elevation myocardial infarction (STEMI) are controversial. (nih.gov)
  • The investigators undertook a systematic, comprehensive analysis of the therapeutic response and clinical outcomes of reperfusion therapy for acute ST-segment elevation myocardial infarction (STEMI) in 5,470 patients from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 trial. (nih.gov)
  • Zadeh B, Wambach JM, Lambers M, Nassenstein K, Jensen CJ, Bruder O. QRS-T-angle in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) - a Comparison with Cardiac Magnetic Resonance Imaging. (medsci.org)
  • The aims of this study were to describe the extent and time course of oxidative stress and evaluate the prognostic value of oxidative stress markers in patients who experienced ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock. (muni.cz)
  • In this substudy of the SOCCER trial, we aimed to evaluate the effects of O 2 -treatment on myocardial function in patients with ST elevation myocardial infarction (STEMI). (lu.se)
  • BACKGROUND: Current practice guidelines support the use of unfractionated heparin, low molecular weight heparin, bivalirudin, or fondaparinux in non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI). (duke.edu)
  • Professor and Cardiologist Gemma Figtree has observed an increasing proportion of ST-elevation myocardial infarction in patients with no relevant risk factors. (bpno.dk)
  • People who have a non-ST elevation myocardial infarction (NSTEMI) are often managed with the blood thinner heparin, with the additional use of PCI in those at high risk. (wikipedia.org)
  • When there is evidence of an MI, it may be classified as an ST elevation myocardial infarction (STEMI) or Non-ST elevation myocardial infarction (NSTEMI) based on the results of an ECG. (wikipedia.org)
  • Results Nine studies (7655 patients) were identified, 6 in the ST-segment elevation AMI patients treated with invasive revascularization and three in mixed AMI type cohorts with variable reperfusion strategies. (srce.hr)
  • Hyper-acute cardiovascular magnetic resonance T1 mapping predicts infarct characteristics in patients with ST elevation myocardial infarction. (ox.ac.uk)
  • We sought to investigate the role of cardiovascular magnetic resonance T1 mapping in the determination of myocardial injury very early after treatment of ST-segment elevation myocardial infarction (STEMI). (ox.ac.uk)
Primary percutaneous coronary int3
STEMI14
  • In young AMI patients, anterior wall STEMI was the most common site and single vessel disease was the most common finding in coronary angiography. (lww.com)
  • Our aim was to compare short-term mortality in patients with STEMI who received either intravenous magnesium sulphate or placebo. (nih.gov)
  • We did a randomised, double-blind trial in 6213 patients with acute STEMI who were assigned a 2 g intravenous bolus of magnesium sulphate administered over 15 min, followed by a 17 g infusion of magnesium sulphate over 24 h (n=3113), or matching placebo (n=3100). (nih.gov)
  • Early administration of magnesium in high-risk patients with STEMI has no effect on 30-day mortality. (nih.gov)
  • In view of the totality of the available evidence, in current coronary care practice there is no indication for the routine administration of intravenous magnesium in patients with STEMI. (nih.gov)
  • Prompt effective reperfusion therapy for acute STEMI may attenuate major myocardial necrosis. (nih.gov)
  • 169 patients with STEMI obtained a standardized digital 12-lead EKG on admission for the calculation of the QRS-T angle and underwent CMR imaging for analysis of infarct size by LGE within the first week. (medsci.org)
  • Methods: Plasma/serum levels of selected biomarkers of oxidative stress (oxidised guanine species (OGS), malondialdehyde, and glutathione peroxidase 3) and markers, which simultaneously reflect severe cellular damage (ferric ion reducing antioxidant power (FRAP), Cu/Zn-superoxide dismutase (SOD), and glutathione) were measured seven times per week in a prospective cohort of 82 patients with STEMI complicated by cardiogenic shock. (muni.cz)
  • Methods: Normoxic (≥94%) STEMI patients were randomized in the ambulance to either supplemental O 2 or room air until the end of the percutaneous coronary intervention (PCI). (lu.se)
  • Conclusion: The present findings indicate no harm or benefit of supplemental O 2 on myocardial function in STEMI patients. (lu.se)
  • Our results support that it is safe to withhold supplemental O 2 in normoxic STEMI patients. (lu.se)
  • METHODS: Between January 2007 and June 2009, data were captured for 72,699 patients with NSTEMI and 48,943 patients with STEMI at 360 U.S. hospitals for the NCDR ACTION Registry-GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines). (duke.edu)
  • RESULTS: At least 1 anticoagulant was administered to 66,279 patients (91.2%) with NSTEMI and 46,149 patients (94.3%) with STEMI. (duke.edu)
  • METHODS:STEMI patients underwent 3 T cardiovascular magnetic resonance (CMR), within 3 h of primary percutaneous intervention (PPCI). (ox.ac.uk)
Ischemia4
Methods6
  • Methods From January 2006 to December 2009, 200 consecutive AMI patients admitted in cardiology department of affiliated hospital of putian university were enrolled. (bmj.com)
  • CDAD patients were signifi cantly more likely than controls to Methods be discharged to a long-term-care facility or outside hospital. (cdc.gov)
  • Methods: We studied 76 patients, from June 2006 to November 2009, who participated in a 10-week cardiac rehabilitation program following a recent (within 3 months) myocardial infarction or unstable angina. (nih.gov)
  • Methods - Preventive services used before the AMI event were examined in a cohort of 30,491 patients with first-time AMI in Ontario, Canada from 2010 to 2012. (ices.on.ca)
  • METHODS: In this case-control study, we compared 98 patients with AMI (case group) and an equal number of age- and sex-matched healthy subjects (control group). (ac.ir)
  • Methods: We included patients with CS in absence of AMI from the 2013-14 HCUP's National Readmission Database. (elsevierpure.com)
Cardiogenic shock8
  • The only therapy proven to reduce mortality for patients with cardiogenic shock is early revascularization. (nih.gov)
  • Introduction: Cardiogenic shock is a frequent complication of acute myocardial infarction. (muni.cz)
  • PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. (bvsalud.org)
  • In patients who have acute myocardial infarction with cardiogenic shock , early revascularization of the culprit artery by means of percutaneous coronary intervention (PCI) improves outcomes. (bvsalud.org)
  • However, the majority of patients with cardiogenic shock have multivessel disease , and whether PCI should be performed immediately for stenoses in nonculprit arteries is controversial. (bvsalud.org)
  • In this multicenter trial , we randomly assigned 706 patients who had multivessel disease, acute myocardial infarction , and cardiogenic shock to one of two initial revascularization strategies either PCI of the culprit lesion only, with the option of staged revascularization of nonculprit lesions, or immediate multivessel PCI. (bvsalud.org)
  • Among patients who had multivessel coronary artery disease and acute myocardial infarction with cardiogenic shock , the 30-day risk of a composite of death or severe renal failure leading to renal-replacement therapy was lower among those who initially underwent PCI of the culprit lesion only than among those who underwent immediate multivessel PCI. (bvsalud.org)
  • Background: Cardiogenic shock (CS) in absence of acute myocardial infarction (AMI) has significant morbidity and mortality. (elsevierpure.com)
Thrombolytic therapy1
Unstable angina2
  • Patients were categorized based on anticoagulant strategy selected during hospitalization and their CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of ACC/AHA [American College of Cardiology/American Heart Association] Guidelines) bleeding risk category. (duke.edu)
  • Unlike the other type of acute coronary syndrome, unstable angina, a myocardial infarction occurs when there is cell death, which can be estimated by measuring by a blood test for biomarkers (the cardiac protein troponin). (wikipedia.org)
Admitted with acute1
Morbidity6
Necrosis1
  • The presence of normal or non-obstructive coronary lesions would suggest possibility of different mechanism of myocardial necrosis. (lww.com)
Delayed in patients with acute1
Percutaneous2
Cardiovascular14
  • The latest data from the Glucose Abnormalities in Patients with Myocardial Infarction (GAMI) study show that glucose abnormalities are twice as common in acute myocardial infarction (AMI) patients who have no history of diabetes as those in sex- and age-matched controls without diabetes and without prior cardiovascular disease. (medscape.com)
  • 200 mmol/L. Patients were recruited at coronary care units in 2 hospitals between 1998 and 2000, along with 185 controls matched for age and gender with no known diabetes or cardiovascular disease apart from hypertension. (medscape.com)
  • In patients with type 2 diabetes, several parameters including glucose intolerance, increased body weight, hypertension, hyperglyceridemia and decreased HDL cholesterol level are recognized cardiovascular risk factors (Iqbal et al . (scialert.net)
  • The overall cardiovascular mortality rates are 2-4 times higher in type 2 diabetic patients than in nondiabetic subjects. (scialert.net)
  • Cardiovascular magnetic resonance (CMR) imaging with late gadolinium enhancement (LGE) offers high resolution imaging of myocardial damage. (medsci.org)
  • MI patients with DM present with varying clinico laboratory characteristics as well as experience higher prevalence of adverse cardiovascular events as compared to patients without DM. (physiciansweekly.com)
  • We found that obese patients were younger and were more likely to have cardiovascular risk factors compared with other BMI groups. (nih.gov)
  • Results Risk factors and non-cardiovascular coexisting conditions were similar across patients identified in primary care, hospital admission, and registry sources. (bmj.com)
  • To establish the incidence of myocardial infarction (MI) in ICU patients with co-existing cardiovascular disease (CVD), and explore its association with long-term survival. (manchester.ac.uk)
  • abstract = "PurposeTo establish the incidence of myocardial infarction (MI) in ICU patients with co-existing cardiovascular disease (CVD), and explore its association with long-term survival.MethodsIn a multi-centre prospective cohort study in 11 UK ICUs, we enrolled 273 critically ill patients with co-existing CVD. (manchester.ac.uk)
  • Given the burden of cardiovascular disease and excess mortality in IRD patients, encouraging the use of evidence-based therapies is critical for ensuring the best outcomes in this high risk group. (biomedcentral.com)
  • Scholars@Duke publication: Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines). (duke.edu)
  • KAND-567 (AZD-8797) is under development for the treatment of acute cardiovascular inflammation caused during and after treatment for myocardial infarction, acute respiratory distress syndrome in coronavirus disease 2019 (COVID-19) infection, myocardial infraction (heart attack), ovarian cancer, epithelial ovarian cancer, fallopian tube cancer and peritoneal cancer. (pharmaceutical-technology.com)
  • Cardiovascular magnetic resonance (CMR) characteristics and clinical outcomes of these patients from the DANAMI-3 substudy might help us to understand better. (bpno.dk)
Complications8
  • Current study was aimed to investigate the impact of DM on clinico-laboratory characteristics on in-hospital treatment outcomes among MI patients.o compare the outcome of mesh hernioplasty performed under local anaesthesia in relatively young and older patients regarding wound complications and urinary retention. (physiciansweekly.com)
  • The dental management of these medically compromised patients can be problematic in terms of oral complications, dental therapy, and emergency care. (medscape.com)
  • The dental clinician needs to understand the potential complications that can occur as a consequence of dental treatment of a medically compromised patient and when pretreatment or post-treatment medication or emergency care is indicated. (medscape.com)
  • The present study aims to find out prognostic importance of stress hyperglycemia and incidence of various complications in patients of Acute myocardial infarction (MI) without diabetes mellitus. (webmedcentral.com)
  • Various indicators have been proposed to predict the severity and complications an episode of acute myocardial infarction for example clinical profile, electrocardiogram changes, hemodynamic parameters, cardiac size, metabolic acidosis and cardiac enzymes. (webmedcentral.com)
  • Therefore, the present study was planned to assess the prognostic importance of non diabetic hyperglycemia in acute myocardial infarction and to find incidence of various complications in AMI patients without diabetes mellitus, thereby permitting early initiation of appropriate preventive measures. (webmedcentral.com)
  • Background Optimal glycated haemoglobin (HbA1c) concentrations to minimize large vessel complications and prolong life in diabetes patients are not well established. (bgu.ac.il)
  • In cases of acute myocardial infarction, recent cocaine use is an important prognostic factor in young patients, as it increases the complications of the acute myocardial infarction itself, 5 as well as in-hospital mortality. (revespcardiol.org)
Incidence and outcome2
  • Failure to use linked electronic health records from primary care, hospital care, disease registry, and death certificates may lead to biased estimates of the incidence and outcome of myocardial infarction. (bmj.com)
  • We read with great interest the article published recently by Gili et al, 1 who studied the relationship between cocaine use disorder and the incidence and outcome of acute myocardial infarction by analyzing the Minimum Basic Data Set (MBDS) of 87 hospitals in Spain. (revespcardiol.org)
Clinical10
  • Acute myocardial infarction (AMI) below 45 years of age constitutes a specific subset of population having different risk factors and clinical features as compared to older patients. (lww.com)
  • A cross-sectional retrospective study was conducted involving 187 patients with clinical diagnosis of AMI. (lww.com)
  • [2-5] It has been observed that there is high prevalence of current smoking, hyperlipidemia, obesity, and family history of coronary artery disease (CAD) among young ACS patients and the clinical outcome in this group of ACS patients is better than older population. (lww.com)
  • [6-9] Most of the studies involving young ACS patients are reported from Western countries and presently, there is no contemporary data on the prevalence, risk factors, clinical characteristics, and outcome of such patients in the developing countries and even in Libya. (lww.com)
  • Impact of diabetes mellitus on clinico-laboratory characteristics and in-hospital clinical outcomes among patients with myocardial infarction. (physiciansweekly.com)
  • Participants 21 482 patients with acute myocardial infarction in England between January 2003 and March 2009, identified in four prospectively collected, linked electronic health record sources: Clinical Practice Research Datalink (primary care data), Hospital Episode Statistics (hospital admissions), the disease registry MINAP (Myocardial Ischaemia National Audit Project), and the Office for National Statistics mortality register (cause specific mortality data). (bmj.com)
  • Present study comprised of 50 patients who had evidence of AMI diagnosed by clinical examination, electrocardiogram and other investigations. (webmedcentral.com)
  • Patient nonadherence and clinical inertia negatively affect hypertension management (7). (cdc.gov)
  • KAND-567 is under clinical development by Kancera and currently in Phase II for Myocardial Infarction. (pharmaceutical-technology.com)
  • 3 We should also remember that large biases may be present in the way patients with chest pain are questioned about cocaine use in clinical practice. (revespcardiol.org)
Late gadolinium enhancement2
  • Late gadolinium enhancement (scar imaging) at 0.55T and 1.5T in three example patients with myocardial infarction. (nih.gov)
  • T1 mapping determined the extent (area-at-risk as %left ventricle, AAR) and severity (average T1 values of AAR) of acute myocardial injury, and related these to late gadolinium enhancement (LGE), and microvascular obstruction (MVO). (ox.ac.uk)
Heart Failure6
  • Heart failure (HF) complicating myocardial infarction (MI) is common and may be present at admission or develop during the hospitalization. (nih.gov)
  • 2 In comparison, to avoid 1 death among patients with heart failure or left ventricular dysfunction, 15 patients need to receive ACE inhibitors for 2.5 years. (cmaj.ca)
  • In this trial, Capricor Therapeutics used donor cells derived from the heart to treat patients at risk for developing heart failure after a heart attack. (ca.gov)
  • Primary: Determine whether treatment is safe and causes reduction in cardiac scar size in patients with heart failure after a heart attack. (ca.gov)
  • Patients were classified into complication group (n=145) or complication-free group (n=55) according to the presence or absence of new-onset symptomatic heart failure, arrhythmia or cardiac shock. (bmj.com)
  • Patient with stress hyperglycemia have more adverse events including heart failure, arrhythmias, heart block, re-infarction and mortality. (webmedcentral.com)
Cardiac11
  • Prior studies evaluating patients with a history of coronary artery disease (CAD) who undergo non-cardiac surgery have shown similar mortality outcomes with liberal and restrictive transfusion strategies. (the-hospitalist.org)
  • Data are lacking for transfusion strategies in patients with CAD who experience postoperative MI after non-cardiac surgeries. (the-hospitalist.org)
  • Overweight patients have the lowest risk of all-cause mortality, which may be attributed to their having the lowest risk of non-cardiac death of the groups studied. (nih.gov)
  • Are Ambient Ultrafine, Accumulation Mode, and Fine Particles Associated with Adverse Cardiac Responses in Patients Undergoing Cardiac Rehabilitation? (nih.gov)
  • Conclusions: In cardiac rehabilitation patients, particles were associated with subclinical decreases in parasympathetic modulation, prolongation of late repolarization duration, increased blood pressure, and systemic inflammation. (nih.gov)
  • Cardiac rehabilitation has been defined by the World Health Organization as: „the sum of activiti-es required to influence favorably the underlying cause of the disease, as well as to ensure that patients\' best possible physical, mental and social conditions so that they may, by their own efforts, preserve or resume a place as normal as possible in theier community. (romanianjournalcardiology.ro)
  • Cardiac rehabilitation is essential for ful-ly recovery of post myocardial infarction patient and for prevention of recurrence of the cardiac event. (romanianjournalcardiology.ro)
  • Sudden cardiac death due to myocardial sarcoidosis claims the life of an on-duty fire fighter - Connecticut. (cdc.gov)
  • Its psychometric characteristics were examined in four samples, including two student samples and samples with cardiac and chronic pain patients. (researchgate.net)
  • There were large differences in BRS scores between cardiac patients with and without Type D and women with and without fibromyalgia. (researchgate.net)
  • cardiac and chr onic pain patients. (researchgate.net)
Outcome1
Abstract1
Middle Aged4
  • Using logistic regression, socioeconomic differences in lipid testing, glucose testing, stress testing, electrocardiography (ECG), and echocardiography in middle-aged and older patients were examined. (ices.on.ca)
  • Controlling for other factors, the researchers found that for primary preventive services, low-income middle-aged patients had 13% (95% confidence interval [CI], 0.790-0.967) and 10% (95% CI, 0.812-0.997) lower odds of receiving lipid and glucose testing, respectively, when compared with high-income middle-aged patients. (ices.on.ca)
  • Controlling for other factors, the researchers found that for secondary preventive services, low-income middle-aged and older patients had 24% (95% CI, 1.087-1.415) and 10% (95% CI, 1.012-1.202) higher odds of receiving echocardiography when compared with their high-income counterparts. (ices.on.ca)
  • However, inequities in primary preventive care were found in middle-aged patients receiving lipid and glucose testing, which may have implications for Canadian health policy to ensure healthy aging across the age spectrum. (ices.on.ca)
Infarct size2
  • Secondary endpoints included indices of coronary microcirculatory function, myocardial infarct size, and angiographic, and electrocardiographic analysis. (bham.ac.uk)
  • The characteristics of myocardial injury within 3 h was compared with changes at 24-h to predict final infarct size. (ox.ac.uk)
Prognosis4
Complication1
  • Patients were divided into quartiles based on RDW value (≤12.8%, 12.9%-13.8%, 13.9%-14.7%, ≥14.8%, n=50 in each quartile), and OR of incident complication was calculated by using logistic regression. (bmj.com)
Chest pain3
Conclusion1
Versus3
  • 55 years), diabetics (45.3% versus 62.0% for non-diabetic patients) and hypertensives (47.3% versus 57.8% for non-hypertensive patients). (who.int)
  • Mortality in aborted MI patients compared with those who had true MI was 3.9% versus 4.6% at 30-day and 7.0% versus 7.4% at 1-year. (nih.gov)
  • DIABETIC VERSUS NONDIABETIC PERSONS chemia or infarction, based on the electrocardiogram, is more common in diabetic persons than in nondia- betic persons6,7. (nih.gov)
Mortality among patients1
  • Although these medications have been proven effective in reducing mortality among patients with coronary artery disease, the magnitude of the reduction varies across the different medication classes. (cmaj.ca)
Diabetes8
  • Patients also rarely moved from NGT to diabetes or from IGT to NGT after the first identification. (medscape.com)
  • Hyperhomocysteinemia is a major risk factor for Myocardial Infarction (MI) in patients with type 2 diabetes, in general population of Pakistan. (scialert.net)
  • However, the role of increase plasma homocysteine level in the development of Coronary Heart Disease (CHD) in patients with type 2 diabetes is still unknown. (scialert.net)
  • Therefore this study was designed to determine the relation ship between plasma homocysteine level and the incidence of MI in patients with type 2 diabetes. (scialert.net)
  • It seems clear relationship between hyperhomocystenia and an increase risk of MI in patients with type 2 diabetes. (scialert.net)
  • Clinicians should be more vigilant and mindful of the possibility of myocardial infarction when assessing patients with diabetes with atypical presentations. (bmj.com)
  • Based on the 1989 U.S. National Health Inter- ter 7, adults with diabetes are more likely than those view Survey (NHIS), 3% of men and women without diabetes to have hypert en sion and age 18-44 years who reported having diabetes dyslipidemia (low levels of high-density lipoprotein, also reported having ischemic heart disease. (nih.gov)
  • Patients included had newly incident diabetes, had at least two HbA1c measurements during the 3 years prior to 1 January 2010 without any disruption(s) in Clalit membership between 2010 and 2014. (bgu.ac.il)
Outcomes of patients1
  • The clinico-laboratory profile and in-hospital outcomes of patients with and without DM were compared using chi-squared test or student t-test, where appropriate. (physiciansweekly.com)
HbA1c2
  • Patients with HbA1C values above 6.5 % were considered diabetic and were excluded from the study. (webmedcentral.com)
  • Unadjusted and adjusted extended Cox regression analyses assessed the association between time-dependent average HbA1c level and acute myocardial infarction and all-cause mortality. (bgu.ac.il)
Odds Ratio2
  • At 30 days, 475 (15.3%) patients in the magnesium group and 472 (15.2%) in the placebo group had died (odds ratio 1.0, 95% CI 0.9-1.2, p=0.96). (nih.gov)
  • The baseline-adjusted mortality was significantly lower in patients with aborted MI (odds ratio [OR] 0.76, 95% confidence interval [CI] 0.63 to 0.92, p = 0.005 for 30-day and OR 0.70, 95% CI 0.50 to 0.98, p = 0.035 for one year). (nih.gov)
Young patients2
  • Risk factors was studied, smoking was found in 63.4% of young patients, 44% were had history of dyslipidemia, 14% had history of alcohol drinking and 12% had family history of coronary artery disease. (lww.com)
  • Our young patients tend to have less extensive coronary artery lesions. (lww.com)
Cohort4
  • Many cohort studies and post-hoc analysis of randomized controlled trials reported anemia was associated with hemorrhagic events and ischemic events in ACS patients ( 1 , 5 - 11 ). (frontiersin.org)
  • In a multi-centre prospective cohort study in 11 UK ICUs, we enrolled 273 critically ill patients with co-existing CVD. (manchester.ac.uk)
  • With a large cohort case-patients and noncase patients. (cdc.gov)
  • The objective of this study was to examine socioeconomic disparities in the use of primary and secondary preventive services relevant to the identification and management of heart disease in a cohort of patients with AMI. (ices.on.ca)
Diagnosis5
  • We included patients aged 65 years and older who were discharged from hospital with a diagnosis of myocardial infarction between Apr. (cmaj.ca)
  • Therefore, our study was restricted to patients aged 65 years and older who were discharged from hospital with a diagnosis of myocardial infarction. (cmaj.ca)
  • The accuracy of the most responsible diagnosis of myocardial infarction upon which patients were selected for inclusion has previously been validated. (cmaj.ca)
  • The diagnosis and treatment of acute myocardial infarction (AMI) patients with chronic kidney disease (CKD) is still a challenging problem. (researchsquare.com)
  • If a patient has no response for the first migraine attack treated with frovatriptan succinate tablets, reconsider the diagnosis of migraine before frovatriptan succinate tablets are administered to treat any subsequent attacks. (nih.gov)
Objective1
  • Objective To determine the completeness and diagnostic validity of myocardial infarction recording across four national health record sources in primary care, hospital care, a disease registry, and mortality register. (bmj.com)
Risk9
  • In our young AMI patients, smoking was the single most important modifiable risk factor, other conventional risk factors are less strongly associated than older patients. (lww.com)
  • The aim of this study was to assess the prevalence and risk factors of AMI patients ≤45 years of age from Libya. (lww.com)
  • In a recent meta-analysis involving 233,144 patients pointed out that anemia in patients with ACS was independently associated with a significantly increased risk of early and late mortality ( 1 , 13 ). (frontiersin.org)
  • A part from traditional risk factors of myocardial infarction, recently many reports have suggested that hyperhomocysteinemia plays an important role in myocardial infarction or lower homocysteine levels are associated with lower rates of coronary heart disease and stroke (Okada et al . (scialert.net)
  • However, to the knowledge of the authors, no data have been reported on the comparable relationship between the HCAR and the risk of subsequent death in AMI patients with CKD. (researchsquare.com)
  • OBJECTIVES: The aim of this study was to evaluate anticoagulant use patterns and bleeding risk in a contemporary population of patients with acute coronary syndrome. (duke.edu)
  • There was a 5-fold difference in the rate of bleeding between patients in the lowest and highest CRUSADE bleeding risk groups, which was consistently observed in most anticoagulant groups. (duke.edu)
  • The study concluded that cocaine use disorders increased the risk of myocardial infarction 3-fold, thereby extending hospital stay and increasing costs. (revespcardiol.org)
  • evaluate high risk patients for coronary artery disease. (nih.gov)
Prospectively1
  • Adenosine diphosphate (ADP)-induced platelet aggregation was prospectively determined on day 4 of acute myocardial infarction in 200 consecutive patients, who received clopidogrel 300 mg as a loading dose and 75 mg/day thereafter. (nih.gov)
Evaluate2
  • The present study is to evaluate quality of life of patients with Acute Myocardial Infarction (AMI) and to identify differences reported about quality of life self perception. (bvsalud.org)
  • 5 6 7 Recent initiatives to expand the use of health records for research have been announced in many countries, 8 9 10 11 and in the United Kingdom the National Health Service is now legally required to evaluate patient outcomes. (bmj.com)
Significantly increased1
  • Results: We found elevated OGS levels in patients who died during three months, which persisted significantly increased the next 12 h compared to surviving patients. (muni.cz)
Coronary lesions1
  • However, 13% of patients have normal or non-obstructive coronary lesions. (lww.com)
CHRONIC KIDNEY-1
  • However, the treatment of AMI patients with chronic kidney disease (CKD) still poses a challenge. (researchsquare.com)
Adverse1
  • We examined whether there were sex-related differences in the relationship between hemoglobin levels and adverse outcomes in patients with acute myocardial infarction. (frontiersin.org)
Diabetic patients2
  • There were no major differences in these rises and falls between diabetic and non-diabetic patients. (portlandpress.com)
  • 3. These findings suggest the free-radical activity as assessed by diene conjugate molar ratios was increased after myocardial infarction, but the increase was not significantly different in diabetic and non-diabetic patients. (portlandpress.com)
Characteristics1
  • Using data from the National Hospital Ambulatory Medical Care Survey, a new NCHS report provides how often patients go to the ED closest to their home, and how differences in geography, patient demographics, and hospital characteristics are associated with ED selection patterns. (cdc.gov)
Consecutive1
  • 25 consecutive patients of each group were included in the study. (webmedcentral.com)
Prognostic value1
  • The purpose of this study was to investigate the prognostic value of HCAR in postoperative 2-year mortality of AMI patients with CKD undergoing coronary angiography(CAG). (researchsquare.com)